Leader Perspectives: Achieving Consistency in Validating & Operationalizing the AI / ML Automation Efforts Transforming Biopharma

3:50 PM - 4:20 PM

This session will feature a panel of leaders discussing emerging forces that are shaping the global future of biopharma, and how intelligent automation and AI is transforming how we work. The session will include discussions on the current technology landscape in biopharma, particularly in pharmacovigilance; intelligent automation opportunities in PV; and propose consideration for validating intelligent automation technologies in PV to promote inspection readiness and inform third-party development.

Janice Chang, Executive Vice President, TransCelerate BioPharma, Inc.
/* */